FREE LIVE REAL WORLD MASTERCLASS SERIES
Prof. Nawab Qizilbash
Senior Clinical Epidemiologist, Head of OXON Epidemiology and:
- Honorary Senior Lecturer in Epidemiology, London School of Hygiene and Tropical Medicine, London University
- Clinical Observer, Internal Medicine, Hospital Cantoblanco & La Princesa, Madrid
- Member of Green Templeton College, Oxford University
- Co-author of x8 Lancet, x1 JAMA and x3 BMJ publications in epidemiology, pragmatic trials and meta-analysis.
- Chief editor of 'Evidence-based Dementia Practice' published by Blackwells, Oxford.
- ENCePP Methods Guide: Primary author of the Annex on systematic review and meta-analysis of safety studies (revised in 2021 with a PRAC member) and co-author of the chapter on primary data collection studies.
Formerly, Nawab Qizilbash was Director of Clinical Epidemiology, GSK; he trained under and worked with Professor Sir Richard Peto F.R.S., (Inventor of: Logrank test, Peto one-step method for pooling odds ratios, adjustment for regression dilution, pioneered large simple trials, and individual-participant meta-analysis, and ´Peto's Paradox), and was the founding editor of the Cochrane Dementia Group. He also trained in general internal medicine and geriatrics under Professor Sir John Grimley Evans and was Honorary Consultant Physician at the Radcliffe Infirmary, Oxford.
Among CROs in Europe, Nawab provides sponsors with a rare combination of high quality epidemiological and clinical experience covering many therapeutic areas.
Mastering RWE Studies in the Healthcare Landscape of South Korea
Dr Ju Hwan Kim
Research Assistant Professor of Pharmacoepidemiology and Pharmacovigilance, School of Pharmacy, Sungkyunkwan University, South Korea.
Dr Ju Hwan Kim earned his PharmD from the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey in 2017. He then received PhD in Pharmacoepidemiology at the School of Pharmacy, Sungkyunkwan University, South Korea in 2022. Currently, Dr. Kim serves as a Research Assistant Professor in the Department of Biohealth Regulatory Science at the School of Pharmacy, Sungkyunkwan University.
As both a pharmacoepidemiologist and clinical pharmacist, his research focuses on RWD and RWE generation, comparative effectiveness and safety research, vaccine safety evaluation, and clinical pharmacy and practice. A significant portion of Dr. Kim's published works center around the utilization of RWD in South Korea, leveraging databases such as the National Health Insurance System (NHIS) database, the Korea Immunization Registry Information System, and Electronic Health Records.
Mastering RWE Studies in the Healthcare Landscape of the UK
Prof. Thomas MacDonald
Professor of Clinical Pharmacology & Pharmacoepidemiology, University of Dundee, and Honorary Consultant Physician at Ninewells Hospital and Medical School.
Tom MacDonald is a Professor of Clinical Pharmacology & Pharmacoepidemiology at the University of Dundee and Honorary Consultant Physician at Ninewells Hospital & Medical School, Dundee, Scotland, UK, and current Director of MEMO Research and the Hypertension Research Centre (HRC) within the Medical School at the University, which has access to the MEMO and the CPRD databases.
He is active in a number of learned societies and is a past president of both the International Society of Pharmacoepidemiology (ISPE) and the British & Irish Hypertension Society (BIHS) and Deputy Chair of the steering committee of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP).
His research interests are hypertension, cardiovascular disease, pharmacoepidemiology and drug safety and innovative trial designs. He has published extensively on drug safety, especially the safety of non-steroidal anti-inflammatory drugs (NSAIDs). He has also published many studies of hypertension and other cardiovascular risk factors and cardiovascular disorders.
Mastering RWE Studies in the Healthcare Landscape of Japan
Prof. Masao Iwagami
Clinical Epidemiologist and:
- Professor in the Institute of Medicine, University of Tsukuba, Japan,
- Honorary Assistant Professor in the Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine (LSHTM), UK.
Dr Masao Iwagami graduated from the University of Tokyo in 2008, completed his internship and nephrology residency in Japanese hospitals, received the Educational Commission for Foreign Medical Graduates certificate in the USA in 2010, and worked as a Research Assistant Professor in the Department of Haemodialysis and Apheresis, the University of Tokyo Hospital in 2013.
He studied clinical epidemiology at the School of Public Health, the University of Tokyo in 2012, at MSc Epidemiology in 2013/2014 and PhD Epidemiology and Population Health in 2014-2018 at LSHTM.
He has received several awards (such as the Kidney International Reviewer-of-the-Year Award in 2021 and 2024) and published over 200 original articles in major journals (such as Lancet Healthy Longevity using the UK CPRD, Lancet Regional Health Western Pacific using the Medical Data Vision database in Japan, and Drug Safety using the JMDC database in Japan). He is the Associate Editor of Pharmacoepidemiology and Drug Safety, and editorial board member of Kidney International, as well as Journal of Epidemiology.
Mastering RWE Studies in the Healthcare Landscape of France
Dr Patrick Blin
Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of the Ethics and Scientific Committee for Health Research, Studies and Evaluations (CESREES)
Dr Patrick Blin (MD, MSc) is a public health physician and a biostatistician with 40 years of leadership in epidemiology and pharmaco-epidemiology. His main area of interest is the evaluation of the performance of drugs and devices in real world setting (Real World Evidence or RWE), especially using the SNDS French nationwide claims database, and link between clinical data and the SNDS, with a large experience in the application of high-dimensional propensity scores for comparative effectiveness and risk comparison studies.
He was born in Paris (France) and studied at the Bicêtre Faculty of Medicine of Paris Saclay University, followed by a Master of Biomathematics (Sorbonne university) with Professor Alain-Jacques Valleron, member of the French Academy of Sciences. After a year in an inter-African public health organization, he participated for 3 years in the establishment of a biostatistics department at the St Louis Paris University Hospital, before heading departments of biostatistics in the pharmaceutical industry for 3 years. He was then the scientific director of CRO specialized in epidemiology and pharmaco-epidemiology for about twenty years. During this period, he collaborated many times with the Bordeaux PharmacoEpi platform of the Bordeaux University in the early 1990s, and became its Scientific and Medical Director between 2012 and 2022. He is now an independent consultant in pharmacoepidemiology.
He has been appointed by decree, member of the Expert Committee for Health Research, Studies and Evaluations (CEREES), then to the Ethics and Scientific Committee for Health Research, Studies and Evaluations (CESREES), of which he is Vice-President since the beginning; Both committees reviewing scientific and public interest of studies using secondary data before CNIL French Data Protection Agency authorization. He is also a member of the National Commission for Research Involving Humans (CNRIPH). He has co-authored over 130 papers in peer-reviewed journals with more than 4,000 citations, and has been a member of the scientific committee for numerous epidemiology and pharmaco-epidemiology conferences.
Mastering RWE Studies in the Healthcare Landscape of Italy
Prof. Carlo Giaquinto
Professor and Head of the Referral Centre for Paediatric HIV infection, Department of Paediatrics, University of Padua and President of the PENTA foundation
Professor Carlo Giaquinto is head of several organisations including, Head of the Referral Centre for Paediatric HIV infection at the Department of Paediatrics of the University of Padua since 1993, Head of the Paediatric European network treatment AIDS (PENTA network) since 1994 and co-chair of the EU funded Network of Excellence TEDDY (Task Force in Europe for Drug Development in the Young). He is also president of the PENTA foundation, one of the most prominent scientific organisations dedicated to paediatric research, and chairman of the Paediatric Rotavirus European Committee (PROTECT) group. He is also the chair of the GRIP project (Global Research in Paediatrics) an EU funded network of Excellence.
Dr Giaquinto is the coordinator for various projects, including several social AIDS projects funded by the EU and by other international organisations both in Europe and Africa. He is the coordinator of Pedianet: a primary care paediatric database. He has served as an honorary senior lecturer in the centre for paediatric epidemiology and biostatistics of the Institute of Child Health in London since 2002.
Furthermore, he has more than 360 full papers published in peer review journals as main author, as main member pf the writing committee or as a main participant for collaborative research and has participated as speaker at more than 300 conferences and international workshops across the world.
Mastering RWE Pregnancy Studies
Prof. Helen Dolk
Professor of Epidemiology and Health Services Research at Ulster University
Helen Dolk has been Professor of Epidemiology and Health Services Research at Ulster University since 2000. Prior to 2000, she was Senior Lecturer in Environmental Epidemiology at London School of Hygiene and Tropical Medicine and completed her doctorate in epidemiology at the Catholic University of Louvain, Belgium in 1991.
Her research experience is mainly in perinatal epidemiology, pharmacoepidemiology and environmental epidemiology. She has been particularly committed to the prevention of congenital anomalies via the identification and modification of environmental factors, whether medicines used in pregnancy, environmental pollutants, or nutritional factors.
For 15 years (until 2014) she was Project Leader of EUROCAT: European Surveillance of Congenital Anomalies, funded by EU DGSanco. From 2011-2015, she led the EUROmediCAT project funded under EU FP7, and has since participated as co-investigator in various pharmacoepidemiology projects including the ConcePTION Consortium (2019-2024) and MumPredict.
Since 2015, she has been working on birth defect surveillance in Latin America and subSaharan Africa, setting up the Global Birth Defects initiative, which has developed an app for the description and recording of birth defects in low and middle income countries (globalbirthdefects.tghn.org).
Mastering RWE Studies: Evaluation of Risk Minimization Measures
Prof. Antoine Pariente
Professor of Pharmacology, Pharmacoepidemiology and Pharmacovigilance, Director of the Department of Public Health & of the BPH AHeaD team - University of Bordeaux (ex-PRAC member)
Antoine Pariente did his MD in Pharmacology and Public Health and completed his training with a PhD in Pharmacoepidemiology focusing on population impact of drugs in dementia.
He is professor of Pharmacology, Pharmacoepidemiology and Pharmacovigilance at the University of Bordeaux, where he heads the Department of Public Health and the Bordeaux Population Health AHeaD (Assessing Health in a Digitalizing real-world setting) team created from the merging of the Pharmaco, ERIAS (headed by Gayo Diallo), and IETO (headed by Emmanuel Lagarde) teams.
Previously he headed the Bordeaux Pharmacovigilance Centre (2016 to 2021) and coordinated the DRUGS-SAFE (Drugs Systematized Assessment in Real-liFe Environment) French National Platform for Pharmacoepi, an academic platform which mission was to provide the French Agence nationale de Securité du Médicament with real-world evidence to support decision-making on drugs (2016 – 2019) In 2020, this platform was transformed into the DRUGS-SAFEr Academic Center for Pharmacoepi which aims to support both the ANSM and the French Health Insurance in their decision-making on drugs.
From 2016 to 2020, he chaired the Bordeaux Population Health research team “Pharmacoepidemioloy-Drugs and Population Health” and in 2018 he was appointed as a scientific independent expert towards the European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC), where he was selected to chair the Interest Group for Impact of Pharmacovigilance regulatory Actions Assessment until 2021.
Mastering RWE Studies in the Healthcare Landscape of the Nordics
Prof. Morten Andersen
Professor of Pharmacovigilance at the University of Copenhagen (UCPH), Pharmaceutical Informatics, Department of Drug Design and Pharmacology.
Prof. Morten Andersen graduated in Medicine from UCPH in 1986 and specialized in Clinical Pharmacology in 1998 after completing his PhD on spontaneous adverse reaction reporting in Denmark. Andersen began his academic career at the University of Southern Denmark, serving in the Clinical Pharmacology and General Practice research units from 1995 to 2009, becoming an Associate Professor in 1999, and leading the Drug Utilisation Research Group until 2010.
Following this, he joined Karolinska Institutet as a Visiting Professor at the Centre for Pharmacoepidemiology and Senior Physician at the Department of Clinical Pharmacology, Karolinska University Hospital, 2010 to 2014, subsequently as Senior Researcher.
In December 2016, he assumed his current role at UCPH, leading the Pharmacovigilance Research Group. Current research areas include continuous safety surveillance and signal detection in healthcare data and applying big data analytics, artificial intelligence and machine learning to healthcare challenges. His work includes leading the Nordic COllaborative Health REgister Network for Covid-19 Epidemiology (Nordic COHERENCE).
He is associated with the Center for Pharmaceutical Data Science and actively involved with the multidisciplinary Pharmacoepidemiology Research Collaboration at UCPH which participates in significant European pharmacoepidemiology networks.
Andersen is a member of the WHO International Working Group for Drug Statistics Methodology. He has supervised numerous PhD and Master's students and has published more than 200 scientific articles. Furthermore, he has participated in extensive speaking engagements, including over 100 scientific conferences.